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Abstract
Background: The usefulness of musculoskeletal ultrasonography (MSUS) in paediatric population is limited by lack
of reference values. One of such parameters is hip joint capsule thickness, postulated as an early measure for
synovitis. However, the joint capsule is hardly a distinguished structure from slit synovial cavity in patients with little
or no fluid collection. Therefore, in patients without effusion, it is more convenient to measure hip joint capsule
thickness together with synovial cavity.
The aim of the study was to establish percentile chart for hip joint capsule and synovial cavity thickness (HJC&SCT)
in apparently healthy children.
Material and methods: The analysis included 816 US of hip joint in 408 children without musculoskeletal disorders,
distributed equally throughout the whole developmental period in 18 one-year subgroups. Hip joints US was
performed according to standard protocol including measurement of HJC&SCT in a single rheumatology centre by
three investigators.
Results: The 3rd, 10th, 25th, 50th, 75th, 90th, and 97th HJC&SCT percentile curves were depicted in the age and height
charts for the combined group of girls and boys. The median HJC&SCT values were increasing with age from 3.7
(C10 - C90: 3.3 – 4.2) mm in the first year of life up to 6.7 (5.8 – 7.3) in 16 years old, and above. In a similar way
the increase was seen with height from 3.9 (3.5 – 4.7) mm in shorter than 95 cm to 6.9 (6.2 – 7.4) mm in taller
than 169 cm subjects. Intra-observer and inter-observer mean precision was less than 1.8 and 12.5%, respectively.
Conclusion: The developed centile chart for hip joint capsule and synovial cavity thickness in the paediatric
population is expected to improve detection of hip joint capsule disorders, including synovitis in juvenile
idiopathic arthritis.
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Background
Musculoskeletal ultrasonography (MSUS) is a well-estab-
lished relevant tool in the management of rheumatic and
musculoskeletal diseases [1]. It allows evaluation of intra-
articular and periarticular structures including diagnosis
of synovial disease [2]. In paediatric rheumatology ultra-
sonography (US) can detect synovitis in patients with
juvenile idiopathic arthritis (JIA) in various joints
involvement (metacarpophalangeal, metatarsophalangeal,
interphalangeal, wrist, ankle, knee, subtalar) and differenti-
ated agreement with radiological imaging [3–11]. MSUS
has an advantage over clinical examination in the detec-
tion of synovitis. It was shown that MSUS may also detect
subclinical synovitis [7, 9, 10], and it persistent form in
clinically inactive JIA [11]. Magni-Manzoni et al. showed
that MSUS may detect subclinical synovitis in clinically
normal joints in JIA patients [5]. They detected synovitis
in 86 joints (5.5%) in 32 children with JIA performing
evaluation of 52 joints [5]. Similarly, Silva et al. diagnosed
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subclinical synovitis using MSUS in 34.4% of children with
JIA [10].
Few studies assessed hip synovitis in JIA patients ap-
plying US [7, 10, 11]. In children with JIA and active
arthritis of the hip joint MSUS revealed pathological
widening of the synovial joint space in 61% examinations
[7]. Others reported only bone irregularities (erosions)
in 4 hips, but no subclinical synovitis [11].
Collado et al. [12] in a systematic literature review fo-
cused on US as the imaging tool in the diagnosis and
management of synovitis in JIA disclosing different def-
inition used for synovitis by authors. US can evaluate
synovitis at the anatomic and vascular levels. The gray-
scale setting enables visualization of synovial hypertrophy
and effusion, whereas the power Doppler settings allow
for detecting changes in the microvascular blood flow in
synovitis. The scoring system developed by the Outcome
Measures in Rheumatology (OMERACT) [13] providing
definitions of common pathological lesions in patients
with inflammatory arthritis, cannot be applied in the
paediatric population, as the normal values – percentile
charts for healthy children for synovial hypertrophy were
not established. Synovial membrane is hardly distinguished
from the other structures of hip joint capsule and slit syn-
ovial cavity in patients with little [14] or no fluid collection,
therefore we have measured the distance from outer sur-
face of the capsule to the cartilage and name it hip joint
capsule and synovial cavity thickness (HJC&SCT). Similar
approach was applied by Rohrschneider at al. [15], who
measured neck-capsule distance (NCD) of hip anterior re-
cess in 166 asymptomatic children aged from 4 months to
17 years, and correlated it to growth (height).
Aim of the study
Establishing percentile chart for hip joint capsule and
synovial cavity thickness (HJC&SCT) in apparently healthy
children.
Methods
The analysis included 816 measurements of hip joint
capsule thickness in 408 children without musculoskel-
etal disorders, distributed equally throughout the whole
developmental period in 18 one-year subgroups, referred
to one rheumatological centre (Department of Older
Children with subunits of Neurology and Rheumatol-
ogy, St. Louis Regional Specialised Children’s Hospital in
Cracow). Musculoskeletal disorders were excluded on
the basis of clinical examination, laboratory findings and
follow up observation.
We included patients diagnosed for increased anti-
streptolysin O (ASO) titre, defective mineralization,
back pain, and connective tissue diseases. Patients with
symptoms of hip involvement, gait disturbances and
limping, asymmetry of body (scoliosis, asymmetry of
lower extremities length), and history of developmental
disorders (e.g. dysplasia), injuries, transient arthritis
(coxitis fugax), juvenile idiopathic arthritis (JIA), how-
ever, other rheumatic diseases were excluded.
The ultrasound (US) evaluation of the hip joints was
performed according to standard protocol including
measurement of hip joint capsule thickness by 3 paediatric
rheumatologist trained in musculoskeletal sonography
(ZZ, MS and AMM). Data were prospectively collected
from July 2010 to June 2016.
The investigators obtained approval for Bioethics Com-
mittee (99/KBL/OIL/2010) for performing US measure-
ments in paediatric patients and their use for research.
Patients and parents gave informed consent for the
performing of US.
Ultrasound examination of the hip joints
The US evaluation in each patient was performed bilat-
erally on hip joints. Images were obtained with a Philips
model HD 11 XE ultrasonography machine equipped
with a 7.5-12 MHz liner transducer (accuracy 0.1 mm).
A standardized procedure similar to that used by other
investigators was followed, a ventral, longitudinal approach
was chosen for the hip [16, 17]. Anterior longitudinal
imaging is a standard procedure in our centre. During
examination a patient lies on his back (supine), with
hips in a neutral position, both legs straight, parallel to
the ground (couch). Feet laid parallel next to each other
at an angle of 90° to the ground. A linear transducer is
applied parallel to the femoral neck, with proximal end
located more medially (inclination angle of approx. 20°).
Obtained images enable visualization of the following struc-
tures: acetabulum with cartilaginous acetabular labrum,
upper extremity (head) of the femur, femoral neck, front
part of the joint capsule (should be parallel to the to the
femoral neck), iliofemoral ligament located above the joint
capsule, iliopsoas muscle (located above the ligament),
tensor fasciae late muscle (partially visible), rectus femoris
muscle, and sartorius muscle (located above the iliopsoas
and tensor fasciae latae muscle). The joint vascularization
is visualized by Color Doppler (CD) and Power Doppler
(PD).
We measure a distance between femoral neck and
joint capsule (the so-called synovial joint space, SJS) – if
visible, and the distance between femoral neck and the
external surface of the joint capsule - HJC&SCT (Fig. 1),
as the separate measurement of SJS is difficult in subjects
without significant collection of the joint fluid.
Intra-observer variability
The inter-observer and intra-observer variability was an-
alyzed on the basis of repeated duplicated measurements
performed for 17 hip joints in 17 randomly chosen
healthy children, independently by 3 sonographers. The
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results of previously performed measurements were
blinded to the other sonographers.
Statistical analysis
Statistical analysis was performed using STATISTICA
10.0 PL (StatSoft, Poland, Cracow). Comparison of
HJC&SCT values between left and right side, for each
age group, was done with the t-Student test for paired
samples. For each age group all required percentiles
were calculated. In the case of height 10 percentiles were
calculated to divide children into the separable height-
groups. Based on percentiles values the second/third
order polynomials with age/height at the x axis were used
to create a centile chart. Based on obtained equations all
percentiles for each age/height group were then calculated
and are presented in tables. In order to assess the relation-
ship between HJC&SCT, the linear regression was used.
The Cook-Weisberg test and Cameron & Trivedi’s decom-
position test was used to test the residuals for heteroske-
dasticity as well as the violation of skewness and kurtosis
assumptions in linear regression. Multicollinearity was
evaluated by calculating the variance inflation factor
(VIF), which should not exceed 5. As a measure of ef-
fect size for regression analysis, we used η2, which is
the proportion of the total variance attributed to an ef-
fect. Larger values of η2 indicate greater influence on
the dependent variable.
The intra-observer variability (mm) was calculated as
a mean difference with 95% confidence interval of two
following HJC&SCT measurement in a set of 34 ran-
domly chosen patients. Intra-rater and inter-observer
variability CV was calculated for this set of patients ac-
cording to Chesher [18].
Results
The analysis of hip joint capsule and synovial cavity
thickness (HJC&SCT) included 816 measurements of
hip joint capsule thickness in 408 apparently healthy
children (254 (62,2%) girls and 154 (37,8%) boys), in 18
one-year subgroups, equally distributed through the
whole of developmental period.
Similar values were observed for corresponding mea-
surements of the left and right hip joints, all p values of
the t-Student test were above 0.05. Mean difference of
HJC&SCT values between left and right hip joints, for
all children, was 0.02 ± 0.31 mm (95% CI: −0.01 ÷ 0.05;
p = 0.11), and maximum difference of 0.5 mm. Therefore
the analysis was performed without separation for the
left and right joint measurements. In addition we showed
no significant difference for girls and boys (mean differ-
ence of HJC&SCT values between groups was −0.09 mm
with 95% CI: −0.25 ÷ 0.06). This justified the combine
analysis for both genders.
The median values of HJC&SCT were increasing with
age from 3.7 (C10-C90: 3.3 – 4.2) mm in the first year of
life up to 6.7 (5.8 – 7.3) mm in 16 years old, and then
remained constant in older children (Table 1 and Fig. 1).
In a similar way median values of HJC&SCT were in-
creasing with height from 3.9 (3.5 – 4.7) mm in shorter
than 95 cm to 6.9 (6.2 – 7.4) mm in taller than 169 cm
(Table 1 and Fig. 2). Similar HJC&SCT values were ob-
served for corresponding height groups of boys and girls.
There was not any patient with synovial effusion,
therefore the synovial joint space was not measured.
Inter-observer and intra-observer variability
We found a high level of agreement between and within
investigators. The intra-observer variability was calculated
Fig. 1 Hip joint capsule and synovial cavity thickness (HJC&SCT) centile chart for age
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for each sonographer separately [mean difference
(95% CI): 0 (−0.34 – 0.34); 0.04 (−0.29 – 0.38); −0.01
(−0.35 – 0.33) mm; corresponding to intra-rater CV:
0.5%; 0.7 and 1.8%]. The inter-observer variability CV
and correlation coefficient between consecutive pairs
of three corresponding sonographers were as follows:
12.3% (r = 0.981; p < 0.001), 12.4% (r = 0.974; p < 0.001)
and 12.5% (r = 0.973; p < 0.001).
Percentile chart
Percentiles for HJC&SCT were calculated for each one
year age group and based on this values centile chart
against age presented on Fig. 1 were created. Based on
those equations all percentiles for each age group were
then calculated and are presented in the Table 1. The
range of centile values changes from 3.21 mm for one
year-old children to 7.83 mm for fifteen year-old children.
In a similar way percentiles for HJC&SCT were calcu-
lated for 10 equinumerous, separable height groups and
are presented on Fig. 2. Based on fitted equations all
percentiles for each height group were then calculated
and shown in Table 1. The range of centile values changes
from 3.22 mm for the shortest children to 8.05 mm for
the tallest children.
Regression analyses
Linear regression coefficients were calculated for the re-
lationship between HJC&SCT and age [for each year
HJC&SCT raised by ® = 0.048 (SE(®) = 0.016; p < 0.01)]
and height [for each centimetre of height HJC&SCT
raised by ® = 0.022 (SE(®) = 0.003; p < 0.001)]. Height had
stronger than age effect on HJC&SCT (η2 = 0.146 and
η2 = 0.024; respectively). A proper usage of the regression
model was confirmed by the Cameron&Trtivedi’s test
(∣2 = 12.82; p = 0.118).
Discussion
To the best of our knowledge this is the largest study
that analysed the hip joint capsule thickness (measured
together with slit synovial cavity) in a healthy paediatric
population and the only one that created the percentile
chart for age and height. Our study revealed that the hip
joint capsule thickness is more related to height than
age and not affected by gender. This allows to score the
thickness of hip capsule in the Caucasian paediatric pa-
tients, and detect variety of synovial abnormalities, in-
cluding inflammatory (synovitis) and non-inflammatory
changes (eg. mucopolysaccharidosis [19, 20]), before ir-
reversible structural changes in cartilage develop [21]. It
is important from clinical point of view, as hip joints are
considered difficult for clinical detection of synovitis in
JIA patients [22]. While, its occurrence may change the
initial diagnosis from oligoarticular to polyarticular cat-
egory, and a long term prognosis.
Routinely performed X-ray imaging is not useful in the
early stage of arthritis due to the lack of sensitivity for
detection of synovitis and synovial effusion. Only mag-
netic resonance (MR) and US imaging are recommended
in patients with synovial involvement. Laurell et al.
demonstrated good correlation of anterior and poster-
ior capsular distance between the US and MR in spon-
taneous external rotation of 10–15° and in internal
rotation of 45° [23].
Early diagnosis of JIA (especially polyarticular) and
introduction of the therapy with disease-modifying anti-
rheumatic drugs (DMARDs) – usually methotrexate –
the current ‘gold standard’ therapy, is improving the
Table 1 The values of 3rd, 10th, 25th, 50th, 75th, 90th, and 97th





C97 C90 C75 C50 C25 C10 C3
Age [yrs]
1 17 5.07 4.18 3.83 3.71 3.47 3.29 3.21
2 13 5.45 4.71 4.33 4.13 3.84 3.62 3.47
3 29 5.80 5.17 4.77 4.51 4.18 3.93 3.72
4 27 6.13 5.56 5.16 4.85 4.49 4.21 3.95
5 20 6.42 5.90 5.50 5.15 4.78 4.47 4.18
6 24 6.69 6.17 5.79 5.42 5.04 4.71 4.38
7 21 6.93 6.40 6.04 5.66 5.27 4.93 4.58
8 23 7.14 6.59 6.25 5.87 5.49 5.13 4.75
9 23 7.32 6.74 6.42 6.06 5.67 5.30 4.92
10 22 7.47 6.86 6.55 6.21 5.84 5.45 5.06
11 22 7.60 6.95 6.66 6.35 5.98 5.57 5.19
12 23 7.70 7.02 6.73 6.46 6.10 5.68 5.30
13 26 7.77 7.09 6.78 6.55 6.20 5.76 5.40
14 30 7.81 7.14 6.81 6.62 6.28 5.82 5.47
15 26 7.83 7.20 6.82 6.67 6.34 5.85 5.53
16 28 7.81 7.25 6.81 6.71 6.38 5.86 5.57
17 24 7.77 7.33 6.79 6.74 6.40 5.85 5.58
18 10 7.70 7.41 6.75 6.75 6.40 5.82 5.58
Height [cm]
< 95 39 5.23 4.69 4.06 3.89 3.62 3.47 3.23
95–106 42 6.01 5.63 5.12 4.79 4.41 4.18 3.93
107–117 42 6.44 6.11 5.65 5.27 4.84 4.58 4.30
118–127 40 6.82 6.51 6.09 5.69 5.22 4.94 4.61
128–137 38 7.10 6.77 6.39 5.99 5.50 5.21 4.83
138–148 41 7.38 7.02 6.64 6.28 5.77 5.48 5.03
149–156 42 7.64 7.22 6.85 6.55 6.04 5.74 5.21
157–162 40 7.80 7.31 6.94 6.69 6.18 5.90 5.31
163–168 40 7.90 7.36 6.99 6.78 6.29 6.01 5.37
≥ 169 44 8.05 7.41 7.03 6.91 6.43 6.17 5.44
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long-term outcome. The shorter interval between symp-
tom onset and the early initiation of aggressive treat-
ment regimen were associated with less joint erosions in
the follow-up period [24, 25]. Involvement of hip joints,
frequent in JIA children with enthesitis-related arthritis
or polyarthritis subtypes, is related with worse long-term
prognosis and increased risk for disability [26], and sub-
sequent hip arthroplasty in young adults [27]. Therefore,
potentially hip US with HJC&SCT measurement may be
apply for detection of subclinical synovitis even without
effusion for selection of patients and that can most
benefit from more aggressive therapy. HJC&SCT meas-
urement might also be useful for synovitis monitoring
during the therapy. However, these hypotheses require
prospective studies.
We would like to stress that HJC&SCT measurement
is quite ease for performing. As previously shown, the
measurement (anterior and posterior capsular distance)
is slightly affected by rotation [23]. Therefore, it should
be performed is one position, regardless the difference
between external rotation and the neutral position was
not significant [15]. A more important seems to be inter-
sonographer variability. In our study, the inter-observer
variability was less than 12.5% and much greater than
intra-observer variability (less than 1.8%), suggesting some
difference in the transducer positioning by sonographers.
Therefore, optimally repeated measurements during pa-
tients follow-up in the centre, should be performed by a
single sonographer.
The main limitation of our study is the lack of com-
parative analysis between US and another imaging
modality as MR, which is believed to be the ‘gold
standard’ in musculoskeletal imaging. However, such a
comparison has been previously performed, showing
good correlation [23]. Furthermore, the sample size of
our cohort is was too small to reveal subtle differences
between boys and girls in the early pubertal period. Fi-
nally, we have included Caucasians only. Consequently
the presented centile chart have to be used with cau-
tion for non-Caucasian populations.
Conclusion
The developed centile chart for hip joint capsule and
synovial cavity thickness in the paediatric population is
expected to improve detection of hip joint capsule disor-
ders, including synovitis in juvenile idiopathic arthritis.
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